ConvaTec
ConvaTec Group plc is a FTSE 100 medical products and technologies company selling chronic-care consumables — wound care, ostomy, continence, and infusion devices — to hospitals, GPOs, and home-care patients across 90 countries, anchored by its proprietary Hydrofiber technology platform.
- Company typePublic
- Founded1978
- HeadquartersReading, United Kingdom
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What ConvaTec does
ConvaTec Group plc is a London-headquartered, FTSE 100 global medical products and technologies company focused on chronic-condition management across four care categories: Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Its product portfolio is anchored by a proprietary Hydrofiber technology platform with 30 years of heritage and nearly 1.5 billion Aquacel dressings sold worldwide, complemented by emerging platforms including ConvaNiox nitric-oxide wound dressings, ConvaMatrix skin substitutes, InnovaMatrix porcine placental ECM, GentleCath intermittent catheters with FeelClean Technology, Esteem Body ostomy systems, and the Neria Guard infusion set for Parkinson's disease treatment. The company sells more than 900 million consumable units annually across approximately 90 countries.
ConvaTec generates revenue primarily through hardware sales of medical devices and consumables to hospitals, healthcare providers, and individual chronic-care patients. Distribution is multi-channel: an enterprise field sales force calling on hospitals and GPOs (with recent wins including Captis/Vizient and Premier, and extensions with Resource Group), direct-to-patient home services via wholly-owned 180 Medical and Amcare in the United States, and an international distributor network. North America accounts for 55.7% of net sales, and the company holds leading positions across all four chronic-care categories. GPO partnerships (Premier, Captis/Vizient, Resource Group), a long-term AbbVie supply contract for Neria Guard, and a $5 million Lilly Foundation/Partners In Health social-impact collaboration represent notable anchor relationships.
The company operates manufacturing in the UK (Rhymney) and Slovakia (Michalovce), with infusion-set production via Unomedical in Mexico, R&D centers supporting the £500 million UK investment and US expansion, and an executive leadership team led by CEO Jonny Mason (appointed November 2025) and CFO Fiona Ryder. Strategic execution centers on the 'Accelerate' strategy with targets of 6-8% organic revenue growth and mid-20s adjusted operating margins by 2027, supported by 11.7% of sales invested in innovation, a $1B+ R&D facility commitment, and a recent AI-powered SAP S/4HANA digital transformation with LTIMindtree. FY2025 results: $2,439M revenue, 22.3% adjusted operating margin, 16% adjusted EPS growth, and ~100% cash conversion.
ConvaTec firmographics
Firmographics- Name
- ConvaTec
- Legal name
- Convatec Group plc
- Website
- https://convatecgroup.com
- Company type
- Public
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- ConvaTec Group plc is a FTSE 100 medical products and technologies company selling chronic-care consumables — wound care, ostomy, continence, and infusion devices — to hospitals, GPOs, and home-care patients across 90 countries, anchored by its proprietary Hydrofiber technology platform.
- Ownership category
- akta.pro rank
ConvaTec industry classification
Industry- Product category
- Chronic Care Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Wound, Ostomy & Continence Care (WOC) at Home (HSABACAE)
- akta.pro secondary industry
- Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)
Keywords
Where ConvaTec is headquartered
LocationHeadquarters
- HQ city
- Reading
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
ConvaTec business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Advanced Wound Care Products: Sales of wound care products including Aquacel dressings, ConvaFoam, ConvaNiox, ConvaMatrix, and related advanced wound care solutions. Revenue grew 4.1% organically excluding InnovaMatrix.
- Ostomy Care Products: Sales of ostomy bags, skin barriers, and accessories including Esteem Body, eakin freeseal, and ESENTA family. Strong growth driven by new patient starts and Esteem Body launch.
- Continence Care Products: Sales of intermittent catheters and continence products including GentleCath Air for Women, serving patients through home services and healthcare providers. Growth driven by volume expansion in North America.
- Infusion Care Products: Sales of infusion sets including Neria Guard for Parkinson's disease treatment and other infusion therapies. Double-digit growth from new customers, products and therapies.
- Home Services: Direct-to-patient supply of catheters and ostomy products through 180 Medical and Amcare home services operations, driving new patient acquisition and customer loyalty.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
ConvaTec product offering
Product offeringCore offering
ConvaTec develops, manufactures, and distributes single-use medical devices and consumables for the management of chronic conditions across four care categories: Advanced Wound Care (Hydrofiber-based dressings such as Aquacel, ConvaFoam, ConvaNiox, ConvaMatrix, InnovaMatrix), Ostomy Care (Esteem Body, Natura Plus, eakin freeseal, ESENTA accessories), Continence Care (GentleCath intermittent catheters), and Infusion Care (Neria and Neria Guard infusion sets). Products are sold directly to hospitals and clinics, through GPO contracts, and to patients at home via the 180 Medical and Amcare home services businesses.
Product overview
Convatec is a global medical products and technologies company focused on solutions for managing chronic conditions, organized into four care categories: Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. The portfolio includes Hydrofiber-based wound dressings (Aquacel™ Ag+ Extra, ConvaFoam™, ConvaFiber™, ConvaNiox™), skin substitute products (ConvaMatrix™, InnovaMatrix®), ostomy systems (Esteem Body™, Natura Plus™, Mouldable Technology, Stomahesive Technology, eakin freeseal®), continence products (GentleCath Air™ for Women with FeelClean Technology), infusion care devices (Neria Guard™, Neria™), and home services businesses (180 Medical, Amcare). The company has launched or secured approvals for five new wound care products since 2022, underpinned by 30 years of Hydrofiber technology. Products are distributed through multiple channels including direct sales, home services, and group purchasing organizations (GPOs) in approximately 90 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Aquacel: Advanced wound care dressing product line utilizing Hydrofiber technology
- ConvaFoam
- ConvaNiox
- ConvaMatrix
- ConvaFiber
- ConvaVAC
- GentleCath
- Esteem Body
- eakin freeseal
- ESENTA
- Neria Guard
- InnovaMatrix
- Flexi-Seal Air
Products and services
- Aquacel Ag+ Extra
Quantifiable outcome
- Delivered 6.4% organic revenue growth excluding InnovaMatrix in FY25
- +4 more outcomes
Companies that use ConvaTec
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles3 records
ConvaTec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
ConvaTec partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Eli Lilly and Company Foundationcore$5 million joint commitment to Partners In Health to support healthcare projects in resource-limited settings focusing on non-communicable diseases and chronic care. Convatec's commitment represents next phase of collaboration with PIH to scale care models and strengthen health systems.
- Eakin HealthcarecoreLongstanding exclusive partnership for co-branded eakin freeseal ostomy seal in North America, extending ESENTA family of skin-friendly accessories. The seal is positioned as thinnest and most absorbent on market, available in air and versa variants.
- Premier, Inc.coreGroup Purchasing Organization agreements for supply of enterostomal therapy products, expanding market access for ostomy care portfolio.
- LTIMindtreeminorStrategic SAP S/4HANA transformation partnership to modernize Convatec's digital infrastructure with AI-powered solutions. Project involves refreshing SAP landscape, streamlining business processes, and enabling AI-powered digital operations across global operations.
- 30 Technology LimitedcoreAcquisition of anti-infective nitric oxide technology platform including product assets, R&D capabilities, and planned 2025 product launch for advanced wound care and infection prevention applications. Total commitment up to £176 million in payments based on regulatory approvals and sales milestones.
- AbbViecorePartnership for Neria Guard infusion set to deliver apomorphine hydrochloride via subcutaneous infusion for Parkinson's disease treatment in US. Device eliminates need for invasive surgery. Long-term supply contract significantly extended.
- Captis/VizientcoreFirst US Ostomy Group Purchasing Organisation contract win in over 5 years, providing access to Vizient member hospitals and healthcare facilities for ostomy products.
Scale indicators13 records
Recent moves8 records
Expansion highlights6 records
ConvaTec competitors and assessment
Company assessmentDirect peers
- Coloplast: Coloplast is the closest direct peer to Convatec, competing head-to-head across ostomy care, continence care and wound care with comparable product categories, global distribution and a strong chronic-care focus. Both companies lead the global ostomy and continence markets.
- Hollister Incorporated: Hollister is a privately held direct competitor in ostomy and continence care, with overlapping product portfolios, similar hospital and home-delivery channels, and a comparable focus on patient quality of life. It is one of Convatec's primary global rivals in ostomy.
- Smith & Nephew: Smith & Nephew is a direct peer in advanced wound care with comparable products (negative pressure wound therapy, advanced dressings, skin substitutes) and overlapping hospital channel relationships. Convatec's ConvaVAC competes directly against Smith & Nephew's PICO system.
- Mölnlycke Health Care: Mölnlycke is a direct competitor in advanced wound care (Mepilex, Mepitel, Avance NPWT) and surgical solutions, with comparable hospital-channel GTM and chronic-wound focus. It is one of the global leaders against which Convatec's Hydrofiber platform competes.
Broad incumbents
- Baxter International: Baxter is a broad incumbent in infusion care and medical devices with overlapping infusion-set products and chronic-care therapies. Convatec's Neria Guard and broader infusion franchise compete for hospital contracts and chronic-disease therapy partnerships.
- Becton, Dickinson and Company (BD): BD is a broad incumbent medical device manufacturer with overlapping products in infusion sets, continence care, and surgical/wound care applications. Convatec competes against BD for hospital GPO contracts across multiple chronic-care categories.
- Cardinal Health: Cardinal Health is a major medical products distributor and manufacturer with overlapping wound care, ostomy and continence products. As a broad incumbent, it competes with Convatec through its own brands and through wholesale distribution channels.
- McKesson: McKesson is a broad medical distributor and healthcare services company that competes with Convatec through wholesale distribution of competing chronic-care products and home-medical-equipment services in North America.
- Owens & Minor: Owens & Minor is a broad medical-products distributor with wound-care, ostomy and continence products that overlap Convatec's hospital-channel offerings. It competes both as a distributor and increasingly as a manufacturer of private-label wound-care products.
Emerging players
- Solventum (formerly 3M Health Care): Solventum was spun out of 3M in 2024 and includes 3M's legacy Health Care business spanning wound care, surgical supplies and skin-health products. It is an emerging competitor in advanced wound care that overlaps Convatec's Hydrofiber and foam dressing categories.
Market position
Strengths5 records
Weaknesses1 record
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
ConvaTec social profiles
Digital presenceConvaTec compliance and trust
Trust signalCompliance7 records
ConvaTec financial estimates
Financial estimateRevenue estimate
Valuation estimate
ConvaTec leadership team
Management profileNumber of profiles
Profiles17 records
ConvaTec subsidiaries and ownership
Company hierarchySubsidiaries6 records
ConvaTec funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ConvaTec M&A and investment
M&A and investmentM&A11 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ConvaTec
What does ConvaTec do?
ConvaTec develops, manufactures, and distributes single-use medical devices and consumables for the management of chronic conditions across four care categories: Advanced Wound Care (Hydrofiber-based dressings such as Aquacel, ConvaFoam, ConvaNiox, ConvaMatrix, InnovaMatrix), Ostomy Care (Esteem Body, Natura Plus, eakin freeseal, ESENTA accessories), Continence Care (GentleCath intermittent catheters), and Infusion Care (Neria and Neria Guard infusion sets). Products are sold directly to hospitals and clinics, through GPO contracts, and to patients at home via the 180 Medical and Amcare home services businesses.
Is ConvaTec a public or private company?
ConvaTec is a public company. It is classified as public and is currently operating.
When was ConvaTec founded?
ConvaTec was founded in 1978. It employs 5,001 to 10,000 people.
Where is ConvaTec based?
ConvaTec is headquartered in Reading, United Kingdom, in the Europe region.
How does ConvaTec make money?
Five revenue lines are on record. Advanced Wound Care Products are the primary driver. The others are ostomy Care Products, continence Care Products, infusion Care Products and home Services.
Who are ConvaTec's main competitors?
Direct peers on record are Coloplast, Hollister Incorporated, Smith & Nephew and Mölnlycke Health Care. Broad incumbents are Baxter International, Becton, Dickinson and Company (BD), Cardinal Health, McKesson and Owens & Minor. Solventum (formerly 3M Health Care) is listed as an emerging player.
Does ConvaTec have an API?
No public API is recorded for ConvaTec.
What industry is ConvaTec in?
ConvaTec's product category is Chronic Care Medical Devices. Its primary akta.pro industry code is HSABACAE, Wound, Ostomy & Continence Care (WOC) at Home, with a secondary code of HSABAKAH, Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies). Its NAICS code is 339113 and its SIC code is 3841.